Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2002

01-11-2002 | Review Article

Follicular Lymphoma in Osaka, Japan: Histological Features and Chronological Change

Osaka Lymphoma Study Group

Authors: Hajime Miyazato, Shin-ichi Nakatsuka, Itsuko Miyanaga, Hitoshi Hanamoto, Yoichi Tatsumi, Mitsuhiro Matsuda, Yasuhiro Maeda, Akihisa Kanamaru, Katsuyuki Aozasa

Published in: International Journal of Hematology | Issue 4/2002

Login to get access
Metadata
Title
Follicular Lymphoma in Osaka, Japan: Histological Features and Chronological Change
Osaka Lymphoma Study Group
Authors
Hajime Miyazato
Shin-ichi Nakatsuka
Itsuko Miyanaga
Hitoshi Hanamoto
Yoichi Tatsumi
Mitsuhiro Matsuda
Yasuhiro Maeda
Akihisa Kanamaru
Katsuyuki Aozasa
Publication date
01-11-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982692

Other articles of this Issue 4/2002

International Journal of Hematology 4/2002 Go to the issue

OriginalPaper

Suicide-Gene-Transduced Donor T-Cells for Controlled Graft-versus-Host Disease and Graft-Versus-Tumor

Case Report

Using Related Donors other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease: A Single Institution Experience in Japan

Case Report

Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis

Review Article

Alkylator-Induced DNA Excision Repair in Human Leukemia CCRF-CEM Cells In Vitro, Measured Using the Single-Cell Gel Electrophoresis (Comet) Assay

Case Report

Acute Myeloid Leukemia (FAB-M2) with a Masked Type of t(8;21) Translocation Revealed by Spectral Karyotyping

Case Report

Filgrastim Treatment of Acute Myelogenous Leukemia (M7) Relapse after Allogeneic Peripheral Stem Cell Transplantation Resulting in Both Graft-versus-Leukemia Effect with Cytogenetic Remission and Chronic Graft-versus-Host Disease Manifesting as Polyserositis and Subsequent Bronchiolitis Obliterans with Organizing Pneumonia
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits